Author: Santillo Vincent M. Lowe Franklin C.
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.23, Iss.10, 2006-01, pp. : 795-805
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Treatment options for benign prostatic hyperplasia
By Thurlow R.J.
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
Dutasteride for the treatment of benign prostatic hyperplasia
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. :
NX 1207 is promising for the treatment of benign prostatic hyperplasia
Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. :
The -blocker terazosin is effective in the treatment of benign prostatic hyperplasia
Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. :
Silodosin: Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia
Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. :